Literature DB >> 12034799

Headache diagnoses in patients with treated idiopathic intracranial hypertension.

Deborah I Friedman1, Elizabeth A Rausch.   

Abstract

The authors reviewed medical records of 82 patients with idiopathic intracranial hypertension (IIH) to determine the frequency of headaches occurring after initial diagnosis and treatment of IIH, classifiable by the International Headache Society guidelines. Sixty-eight percent of patients had definable headache disorders, including episodic tension type headache (30%) and migraine without aura (20%). Patients with IIH frequently have other types of headaches, not necessarily related to increased intracranial pressure.

Entities:  

Mesh:

Year:  2002        PMID: 12034799     DOI: 10.1212/wnl.58.10.1551

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

Review 1.  Pseudotumor cerebri.

Authors:  Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

Review 2.  Tension-type headache mimics.

Authors:  Sara C Crystal; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2011-12

3.  Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.

Authors:  R M Ahmed; M Wilkinson; G D Parker; M J Thurtell; J Macdonald; P J McCluskey; R Allan; V Dunne; M Hanlon; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

4.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 5.  Cerebral venous sinus stenting for pseudotumor cerebri: A review.

Authors:  Sivashakthi Kanagalingam; Prem S Subramanian
Journal:  Saudi J Ophthalmol       Date:  2014-09-27

6.  Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension.

Authors:  Robert Laemmer; Josef G Heckmann; Christian Y Mardin; Stefan Schwab; Alexandra B Laemmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-31       Impact factor: 3.117

7.  Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial.

Authors:  Deborah I Friedman; Peter A Quiros; Prem S Subramanian; Luis J Mejico; Shan Gao; Michael McDermott; Michael Wall
Journal:  Headache       Date:  2017-07-28       Impact factor: 5.887

8.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

Review 9.  The diagnosis and management of idiopathic intracranial hypertension and the associated headache.

Authors:  Rigmor Højland Jensen; Aleksandra Radojicic; Hanne Yri
Journal:  Ther Adv Neurol Disord       Date:  2016-03-21       Impact factor: 6.570

10.  A comparison of idiopathic intracranial hypertension with and without papilledema.

Authors:  Kathleen B Digre; Beau K Nakamoto; Judith E A Warner; Wendy J Langeberg; Susan K Baggaley; Bradley J Katz
Journal:  Headache       Date:  2009-02       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.